Frontiers in Public Health
August 6, 2026
R. Cameron Wolf, Rick Lambert, Sara Shoar et al.
Use of psychedelic substances is increasing across unregulated, state-regulated, research, ceremonial/religious, and medical settings in the United States. Concurrently, a growing body of clinical research signals the potential for therapeutic applications for specific psychedelics in the treatment of depression, post-traumatic stress disorder, substance use disorders, and other health...
Frontiers in Psychiatry
August 6, 2026
Maria Laura Mele, Stefano Federici
IntroductionPsychedelic-assisted therapy (PAT) is an emerging complex intervention for psychiatric and existential conditions (i.e., forms of distress related to meaning, mortality, and identity, such as that arising in life-threatening illness); however, a systematic characterization of the evaluation methods used across the entire clinical intervention remains incomplete. This scoping review...
Translational Psychiatry
August 3, 2026
Meaghan McKenna, Kevin J. Clancy, Christine J So et al.
Distressing dreams or nightmares about a traumatic experience are common among trauma-exposed individuals and contribute to the maintenance of posttraumatic stress disorder (PTSD) symptoms. Like other intrusive reexperiencing symptoms, trauma-related nightmares are characterized by vivid sensory details and heightened emotional intensity. However, little is known about their underlying...
Psychiatry Research
August 1, 2026
C. Bharat, Xin-Tong Huang, G. Campbell et al.
BACKGROUND Interest in cannabinoids for mental and substance use disorders is increasing. We examined experimental and observational evidence for treating these disorders and their symptoms. METHODS Systematic review and meta-analysis (PROSPERO CRD42023467536). We searched CENTRAL, MEDLINE, Embase and PsycINFO to May 2025 for studies of cannabinoids in adults (≥18 years) with ADHD, anxiety,...
Contemporary Clinical Trials
August 1, 2026
Dessa Bergen-Cico, A. Ramon, Benjamin I. Felleman et al.
Psychological distress, encompassing PTSD, depression, and anxiety-is highly prevalent among Veterans receiving care in Veterans Health Administration (VHA) primary care settings, yet it frequently goes untreated or undertreated. Traditional psychotherapies and psychiatric medications are often misaligned with Veterans' preferences for self-reliance, low-stigma formats, and skill-based...
Clinical Neuropharmacology
July 31, 2026
Stephen I Deutsch, Jeffrey Elikan, David Spiegel et al.
Last of the Just, a novel of historical fiction published in 16 languages and recipient of France's highest literary award, is recognized for its scholarly contribution to Holocaust education and conceptualization of the Lamid Vavnik, one of "36 (largely anonymous) Just Men of Jewish Tradition" responsible for sustaining humanity. The book's main character is Ernie Levy, who has clinical...
CNS & Neurological Disorders - Drug Targets
July 31, 2026
Sampriti Paul, Sonal Dubey, Mayur Yergeri Chandrasekharappa et al.
Recent advances in neuropsychopharmacology have renewed interest in psychedelics and entactogens as potential treatments for brain disorders, owing to their rapid effects on neural plasticity, cognition, and affect. Classical serotonergic psychedelics primarily act as 5-HT2A receptor agonists with additional activity at 5-HT1A and other serotonin receptors, whereas entactogens such as MDMA...
PSYCHOLOGICAL JOURNAL
July 30, 2026
Ivan Danyliuk, Nataliia Burkalo
Background. In modern psychology, mindfulness is regarded as a multidimensional psychological phenomenon associated with the deliberate direction of attention to present-moment experience, an open, accepting, and non-judgmental attitude toward that experience, the development of self-regulation and psychological flexibility, and a reduction in automatic emotional and behavioral reactivity....
Medicina contemporânea
July 28, 2026
Larissa Barbosa Lopes, Ana Glaucia Paulino Lima
O interesse científico pelos psicodélicos como alternativa terapêutica para transtornos mentais tem crescido expressivamente nas últimas duas décadas, impulsionado por ensaios clínicos que demonstram resultados promissores em pacientes com depressão resistente ao tratamento, transtorno de estresse pós-traumático, ansiedade relacionada a doenças graves e transtornos por uso de substâncias....
Borderline Personality Disorder and Emotion Dysregulation
July 27, 2026
Max C. Pensel, Johanna M. H. L. Siems, Alexander Blazejak et al.
Abstract: Background: Dissociative symptoms arise in reaction to significant stress and are common in post-traumatic stress disorder (PTSD). Methods: We longitudinally investigated the course of dissociative symptoms in psychiatric patients over the first year of the SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) pandemic situation (04/2020–05/2021). The group was separated into...